HIV prevention policy: latest news

HIV prevention policy resources

HIV prevention policy features

HIV prevention policy news from aidsmap

More news

HIV prevention policy news selected from other sources

  • Empirical evidence that achievement of UNAIDS 90-90-90 can deliver promised HIV elimination?

    Researchers working on the Rakai Community Cohort Study in Uganda claim this is the first study to demonstrate the population level effect of the combination strategy for HIV prevention.

    19 December 2017 | BMJ Group blogs
  • CDC Reportedly Bans Words Including “Transgender” and “Science-Based”

    The Trump Administration is forbidding policy analysts at the nation’s main public health agency from using seven words and phrases, including transgender, fetus and evidence-based, in official documents dealing with the upcoming budget, The Washington Post reported. That assertion is a “complete mischaracterization of discussions,” says an HHS spokesperson.

    19 December 2017 | Poz
  • Australian Labor party commits to $53m plan to 'make HIV history'

    People at high risk of HIV would be given cheap access to a breakthrough preventative medicine under a federal Labor plan to make Australia the first nation in the world to win the fight against the virus that causes AIDS. The opposition's $53 million plan would dramatically expand state trials of the drug PrEP until it is approved for a federal subsidy, increase funding for HIV peak bodies and tackle rising transmission rates in Aboriginal communities.

    11 December 2017 | Sydney Morning Herald
  • Do HIV-Preventing Microbicides Have a Future in the Age of PrEP?

    Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

    11 December 2017 | Poz
  • Undetectable = Untransmittable -- The Noise, the Joys and the Nuances

    Let's focus on how U=U should impact our delivery of HIV care services to people living with HIV. Here are some "musts" on my list.

    11 December 2017 | The Body
  • Setting the Standard: New prevention trials in the era of oral PrEP

    There’s a lot going on in the world of HIV prevention research right now. One key issue is how participants might access oral PrEP as part of HIV prevention trials. It may seem simple: trial participants have the right to the highest standard of HIV prevention and care as part of participation. But the ethics, trial design issues and the mechanisms by which interventions are provided as standard of care are quite complex. Opinions differ and politics abound.

    08 December 2017 | AVAC
  • Why is HIV prevention among young women and girls not working? We have forgotten the men

    Urgent action is needed on two fronts. The first is challenging and transforming harmful gender and social norms that discourage men from seeking health services and behaviours that increase the likelihood of HIV transmission to women and girls. The second is to ensure that health systems in general, and health service delivery specifically, are designed in a way that will meet men where they are with HIV-related services.

    04 December 2017 | Daily Maverick
  • Mixed Messages and how to untangle them: AVAC Report 2017

    In this year’s AVAC Report—Mixed Messages and How to Untangle Them—we have set ourselves the task of clarifying the profoundly complex field of biomedical HIV prevention and research. This is never an easy task, but it is made all the more complicated—and exciting—in the current environment.

    01 December 2017 | AVAC
  • Yusef Azad from National AIDS Trust: The HIV revolution begins?

    It’s been a revolutionary, momentous year in the UK for the gay community and our fight against HIV. 2017 could go down in history as the year we turned the corner and saw the beginning of the end of the epidemic. This World AIDS Day it’s worth reminding ourselves how we got here, and what more there is still to do.

    01 December 2017 | Boyz
  • New HIV guideline outlines cost-effective prevention strategies for high-risk people

    A new Canadian guideline outlines how new biomedical strategies to prevent HIV infection can best be used in high-risk populations both before and after exposure to the virus. The guideline, published in CMAJ, applies to adults at risk of HIV infection through sexual activity or injection drug use.

    27 November 2017 | Eurekalert Medicine & Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.